Immunogen Inc. (IMGN) Posts Q1 Loss of $0.22; Reaffirms Guidance
More News related to IMGN
- ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2010
- ImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual BIO CEO & Investor Conference
- ImmunoGen (IMGN) Reports a Q2 Loss; Comments on FY Outlook
- ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2010 Financial Results
- Trading Radar for 01/28: Amazon.com (AMZN), Microsoft (MSFT), Chubb (CB), AT&T (T), Ford Motor (F), L-3 (LLL) Report
More News related to Earnings
- Forrester Research (FORR) Posts Q4 EPS of $0.35 Tops by 7c; Guides Q110 and FY10
- NetSol (NTWK) Reports Q2 Loss of $0.01, Misses by 2c; Reaffirms Guidance
- Rentech (RTK) Reports Q1 Loss of $0.07
- Textainer (TGH) Tops Q4 Earnings Views
- Sprint Nextel (S) Q4 Losses Narrow, But Miss Expectations
Immunogen Inc. (NASDAQ: IMGN) reports Q1 loss of $0.22, cents better than the analyst estimate of ($0.20). Revenue for the quarter was $3.10 million, which compares to the estimate of $4.54 million.
Reaffirms guidance.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
